ARCHIVES

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976

Knowing Tumor Cell Structure Improves Treatment Decisions

March 27, 2009

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998

AACR Membership Up 14 Percent Per Year Since ‘88

June 8, 1990

In Brief: Pinedo To Receive Josef Steiner Prize; Lurie Cancer Center Gets $2.5M Donation

October 27, 1995

Funding Opportunities

November 15, 2002